Position in ACB
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$2,190,024
-$289,227 QoQ
Shares Held
784,955
+3.5% QoQ
Ownership
1.24%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#3
of 149 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ACB Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026RENAISSANCE TECHNOLOGIES LLC holds $2,242,873,379 across 49 Drug Manufacturers - Specialty & Generic names. ACB ranks #25 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
1,708,739 | $925,846,052 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
2,335,897 | $393,692,080 | |
| 3 | ALKS |
Alkermes plc.
|
6,460,928 | $338,552,627 | |
| 4 | RDY |
Dr Reddys Laboratories Ltd
|
7,347,028 | $106,458,435 | |
| 5 | ZTS |
Zoetis Inc.
|
1,403,300 | $100,841,138 | |
| 6 | SUPN |
Supernus Pharmaceuticals, Inc.
|
1,478,180 | $68,750,151 | |
| 7 | COLL |
Collegium Pharmaceutical, Inc
|
1,366,549 | $49,469,073 | |
| 8 | PCRX |
Pacira BioSciences, Inc.
|
1,733,801 | $43,986,531 |
All Filings in ACB
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,190,024 | 784,955 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $2,479,251 | 758,181 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $3,250,429 | 770,244 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $4,684,887 | 786,055 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $2,906,753 | 685,555 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $2,925,201 | 666,333 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $3,037,283 | 714,655 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $3,870,539 | 658,255 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $2,849,408 | 616,755 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $3,861,751 | 879,670 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $4,902,790 | 10,299,979 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $3,717,920 | 6,355,420 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $3,020,517 | 5,645,827 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $4,048,615 | 5,808,630 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $5,471,991 | 5,928,485 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $5,185,976 | 4,250,800 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $4,250,906 | 3,220,384 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $3,506,000 | 876,500 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $501,507 | 92,700 | Shares | Sole | 2022-02-11 | |
| 2021-03-31 | $2,288,258 | 245,785 | Shares | Sole | 2021-05-13 | |
| 2020-09-30 | $2,080,307 | 447,378 | Shares | Sole | 2020-11-13 | |
| 2020-03-31 | $2,435,685 | 2,688,395 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||